Literature DB >> 17177018

Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child Edition.

Anne W Riley1, David Coghill, Christopher B Forrest, Maria J Lorenzo, Stephen J Ralston, Georg Spiel.   

Abstract

OBJECTIVES: To examine the cross-sectional reliability and validity of the Parent Report Form of the Child Health and Illness Profile-Child Edition (CHIP-CE), a generic measure of health-related quality of life (HRQoL), in children with ADHD in the pan-European ADHD Observational Research in Europe (ADORE) study.
METHODS: Parents of children with ADHD (aged 6-18 years) in 10 European countries completed the CHIP-CE at the baseline visit (n=1,477; data missing for one patient). Analyses included determination of internal consistency reliability, ceiling and floor effects, factor analysis, and Pearson's correlations between CHIP-CE and other scales used to measure ADHD severity, problems and family strain.
RESULTS: Internal consistency reliability was good-to-excellent (Chronbach's alpha>0.70) for all CHIP-CE domains and subdomains, and almost no ceiling and floor effects were observed. Factor analysis of the subdomains yielded a 12-factor solution. The domainlevel factor analysis identified six factors, the four domains of Satisfaction, Comfort, Resilience and Risk Avoidance. The two subdomains of Achievement domain, Peer Relations and Academic Performance, were separate factors in this sample. There were moderate-to-high correlations between the CHIP-CE scales and measures of ADHD and family factors. The HRQoL of children in ADORE was dramatically lower than that of community youth,with mean CHIP-CE scores almost 2 standard deviations below community norms.
CONCLUSIONS: The validity and reliability of CHIP-CE to measure HRQoL in children with ADHD across Europe was confirmed.

Entities:  

Mesh:

Year:  2006        PMID: 17177018     DOI: 10.1007/s00787-006-1009-6

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  17 in total

1.  Psychopathological screening of children with ADHD: Strengths and Difficulties Questionnaire in a pan-European study.

Authors:  Andreas Becker; Hans-Christoph Steinhausen; Gisli Baldursson; Sören Dalsgaard; Maria J Lorenzo; Stephen J Ralston; Manfred Döpfner; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

2.  The Family Strain Index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHD.

Authors:  Anne W Riley; Lisa M Lyman; Georg Spiel; Manfred Döpfner; Maria J Lorenzo; Stephen J Ralston
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

3.  Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK.

Authors:  Louis S Matza; Kristina Secnik; Sally Mannix; F Randy Sallee
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 4.  The effect of ADHD on the life of an individual, their family, and community from preschool to adult life.

Authors:  V A Harpin
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

5.  Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool.

Authors:  Jeanne M Landgraf; Michael Rich; Leonard Rappaport
Journal:  Arch Pediatr Adolesc Med       Date:  2002-04

6.  ADORE -- Attention-Deficit Hyperactivity Disorder Observational Research in Europe.

Authors:  Stephen J Ralston; Maria J M Lorenzo
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

7.  The Parent Report Form of the CHIP-Child Edition: reliability and validity.

Authors:  Anne W Riley; Christopher B Forrest; Barbara Starfield; George W Rebok; Judith A Robertson; Bert F Green
Journal:  Med Care       Date:  2004-03       Impact factor: 2.983

8.  The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder.

Authors:  Louis S Matza; Anne M Rentz; Kristina Secnik; Andrine R Swensen; Dennis A Revicki; David Michelson; Thomas Spencer; Jeffrey H Newcorn; Christopher J Kratochvil
Journal:  J Dev Behav Pediatr       Date:  2004-06       Impact factor: 2.225

9.  The adolescent child health and illness profile. A population-based measure of health.

Authors:  B Starfield; A W Riley; B F Green; M E Ensminger; S A Ryan; K Kelleher; S Kim-Harris; D Johnston; K Vogel
Journal:  Med Care       Date:  1995-05       Impact factor: 2.983

10.  Attention-deficit/hyperactivity disorder: increased costs for patients and their families.

Authors:  Andrine R Swensen; Howard G Birnbaum; Kristina Secnik; Maryna Marynchenko; Paul Greenberg; Ami Claxton
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-12       Impact factor: 8.829

View more
  23 in total

1.  Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment.

Authors:  Anne W Riley; Georg Spiel; David Coghill; Manfred Döpfner; Bruno Falissard; Maria J Lorenzo; Ulrich Preuss; Stephen J Ralston
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

2.  Health status of extremely low-birth-weight children at 8 years of age: child and parent perspective.

Authors:  Maureen Hack; Christopher B Forrest; Mark Schluchter; H Gerry Taylor; Dennis Drotar; Grayson Holmbeck; Laura Andreias
Journal:  Arch Pediatr Adolesc Med       Date:  2011-10

3.  Health-related quality of life in non-paraplegic (ambulatory) children with myelomeningocele.

Authors:  Huseyin Canaz; Gokhan Canaz; Irem Dogan; Ibrahim Alatas
Journal:  Childs Nerv Syst       Date:  2017-06-27       Impact factor: 1.475

4.  Assessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative review.

Authors:  Jeffery N Epstein; Margaret D Weiss
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-29

5.  Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings.

Authors:  Ralf W Dittmann; Peter M Wehmeier; Alexander Schacht; Martin Lehmann; Gerd Lehmkuhl
Journal:  Atten Defic Hyperact Disord       Date:  2009-09-23

6.  Psychometric properties of two ADHD questionnaires: comparing the Conners' scale and the FBB-HKS in the general population of German children and adolescents--results of the BELLA study.

Authors:  Michael Erhart; Manfred Döpfner; Ulrike Ravens-Sieberer
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-12       Impact factor: 4.785

7.  Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents.

Authors:  Pär Svanborg; Gunilla Thernlund; Per A Gustafsson; Bruno Hägglöf; Lynne Poole; Björn Kadesjö
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-01-20       Impact factor: 4.785

Review 8.  The quality of life of children with attention deficit/hyperactivity disorder: a systematic review.

Authors:  Marina Danckaerts; Edmund J S Sonuga-Barke; Tobias Banaschewski; Jan Buitelaar; Manfred Döpfner; Chris Hollis; Paramala Santosh; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Eric Taylor; Alessandro Zuddas; David Coghill
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-07-26       Impact factor: 4.785

9.  An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence.

Authors:  Aribert Rothenberger; Andreas Becker; Dieter Breuer; Manfred Döpfner
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-10       Impact factor: 4.785

10.  Psychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials.

Authors:  Alexander Schacht; Rodrigo Escobar; Thomas Wagner; Peter M Wehmeier
Journal:  Atten Defic Hyperact Disord       Date:  2011-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.